Dexmedetomidine vs midazolam: Postoperative outcome in elderly patients
DOI:
https://doi.org/10.33448/rsd-v13i5.45686Keywords:
Dexmedetomidine; Midazolam; Elderly; Postoperative period.Abstract
Introduction: In 2023, the World Health Assembly organized by the WHO celebrated the milestone of a 50% increase in the global average life expectancy. The impact of this demographic transition in the medical and surgical context is significant, considering the need for greater deliberation related to the increased sensitivity of the elderly to adverse postoperative reactions. Objective: To analyze the impact of using dexmedetomidine medication over midazolam on the postoperative outcome of the elderly patient. Methodology: This is an integrative review of the literature, including 20 articles published between the years of 2018 and 2023 on platforms such as PubMED, Lilacs, BVS, and Google Scholar. The descriptors dexmedetomidine, midazolam, elderly, and postoperative were used, combined with the Boolean operator "AND". Results: Dexmedetomidine was noted for its significant advantages in terms of the number of postoperative delirium cases, psychomotor agitation, respiratory depression, pain, sleep quality, oxygen need, tremors, and residual sedation. It is important to emphasize the protection of cognitive function provided to elderly patients who used it. Conclusion: The administration of dexmedetomidine as intraoperative sedation showed a lower index of postoperative complications in the elderly population when compared to midazolam. However, it is necessary to conduct new studies on the effects of these drugs in isolated contexts, without comparisons with other medications, specifically in the intraoperative and postoperative scenario.
References
Abdel Azeem, T. M., Yosif, N. E., Alansary, A. M., Esmat, I. M., & Mohamed, A. K. (2018). Dexmedetomidine vs morphine and midazolam in the prevention and treatment of delirium after adult cardiac surgery: A randomized, double-blinded clinical trial. Saudi Journal of Anaesthesia, 12(2), 190–197. https://doi.org/10.4103/sja.SJA_303_17.
Andrade, T. R., Salluh, J. I. F., Garcia, R., Farah, D., Silva, P. S. L. da, Bastos, D. F., & Fonseca, M. C. M. (2021). Uma análise de custo-efetividade de propofol versus midazolam para sedação de pacientes adultos admitidos à unidade de terapia intensiva. Revista Brasileira de Terapia Intensiva, 33(3), 428-433. [ID: biblio-1347287].
Bastos, A. S., Beccaria, L. M., Silva, D. C. da, & Barbosa, T. P. (2020). Prevalence of delirium in intensive care patients and association with sedoanalgesia, severity and mortality. Revista Gaúcha de Enfermagem, 41, e20190068.
Cristiano, L., Coppolino, F., Donatiello, V., Paladini, A., Sansone, P., Passavanti, M. B., Pota, V., Giaccari, L. G., Aurilio, C., Sepolvere, G., & Pace, M. C. (2020). Use of Dexmedetomidine in Transfemoral Transcatheter Aortic Valve Implantation (tf-TAVI) Procedures. Advances in Therapy. Advance online publication. https://doi.org/10.1007/s12325-020-01342-w.
Estefó, M., Ojeda, D., Cisternas, P., Arraño, N., & Zanetta, H. (2021). Factores de riesgo de reacción paradójica asociados a sedación endovenosa con midazolam. Revista Médica de Chile, 149(2), 237-241.
Falcón Guerra, M., Orizondo Pajón, S. A., Alonso Valdés, J. A., & Nicolau Cruz, I. (2020). Anestesia intravenosa total: Propofol/remifentanil vs. midazolam/remifentanil en cirugía torácica [Total intravenous anesthesia: propofol/remifentanil vs midazolam/remifentanil in thoracic surgery]. Revista Cubana de Anestesiología y Reanimación, 19(1), e560.
Inatomi, O., Imai, T., Fujimoto, T., Takahashi, K., Yokota, Y., Yamashita, N., Hasegawa, H., Nishida, A., Bamba, S., Sugimoto, M., & Andoh, A. (2018). Dexmedetomidine is safe and reduces the additional dose of midazolam for sedation during endoscopic retrograde cholangiopancreatography in very elderly patients. BMC Gastroenterology, 18(1), 166. https://doi.org/10.1186/s12876-018-0897-5.
Liu, H., Gao, M., Zheng, Y., Sun, C., Lu, Q., & Shao, D. (2023). Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: a randomized controlled trial. Trials, 24(1), 386. https://doi.org/10.1186/s13063-023-07384-z
Li, W.-X., Luo, R.-Y., Chen, C., Li, X., Ao, J.-S., Liu, Y., & Yin, Y.-Q. (2019). Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial. Chinese Medical Journal (Engl), 132(4), 437-445. https://doi.org/10.1097/CM9.0000000000000098
Li, X.-T., Jiang, X.-M., Zheng, Z.-Y., & Huang, H.-S. (2018). [Effect of dexmedetomidine on inflammatory factors level and cognitive function after femoral head replacement in elderly patients]. Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology, 31(12), 1091-1095. https://doi.org/10.3969/j.issn.1003-0034.2018.12.003.
Mansouri, N., Nasrollahi, K., & Shetabi, H. (2019). Prevention of Cognitive Dysfunction after Cataract Surgery with Intravenous Administration of Midazolam and Dexmedetomidine in Elderly Patients Undergoing Cataract Surgery. Advanced Biomedical Research, 8(6). https://doi.org/10.4103/abr.abr_190_18
Miñarcaja, M, Estrella, A., & Vallejo Martínez, M. (2023). Control de síntomas al final de la vida con Dexmedetomidina: Estudio observacional de centro único. Oncología (Guayaquil), 33(2), 143-152. [ID: biblio-1451570]
Park, S. W., Choi, J.-H., Kim, H.-T., & Cho, Y. H. (2018). Replacement of dexmedetomidine loading with midazolam for sedation in elderly patients with spinal anesthesia. Medicine, 97(39), e12565. https://doi.org/10.1097/MD.0000000000012565
Rajaei, M., Tabari, M., Soltani, G., Alizadeh, K., Nazari, A., Noroozian, M., & Morovatdar, N. (2019). Comparison between the effects of dexmedetomidine and midazolam on postoperative cognitive impairment after coronary artery bypass graft surgery: A randomized clinical trial. Journal of Tehran Heart Center, 14(2), 67-73. https://doi.org/10.18502/jthc.v14i2.1702
Shen, Q.-H., Li, H.-F., Zhou, X.-Y., & Yuan, X.-Z. (2020). Dexmedetomidine in the prevention of postoperative delirium in elderly patients following non-cardiac surgery: A systematic review and meta-analysis. Meta-Analysis. Advance online publication. https://doi.org/10.1111/1440-1681.13312
Silva-Jr, J. M., Katayama, H. T., Nogueira, F. A. M., Moura, T. B., Alves, T. L., & de Oliveira, B. W. (2019). Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients: a randomized clinical trial. Regional Anesthesia and Pain Medicine. Advance online publication. https://doi.org/10.1136/rapm-2018-100120
Soto, G., Harvey, G., Glavinovich, I., García, V., Urchipia, C., & Beche, N. (2020). Comparación midazolam vs dexmedetomidina en pacientes con síndrome de apnea obstructiva del sueño. Revista Chilena de Anestesia, 49(5), 675-682. [ID: biblio-1512215]
Wang, W., Feng, N., Zhao, W., Luo, F., Zhu, X., Zhao, W., Liu, Z., & Xu, L. (2018). Dexmedetomidine reduces brain neuronal injuries but not clinical neurocognitive function in the elderly, compared to midazolam. International Journal of Clinical and Experimental Medicine, 11(2), 1471-1478. ISSN: 1940-5901/IJCEM0079860.
Zeng, K., Long, J., Li, Y., & Hu, J. (2023). Preventing postoperative cognitive dysfunction using anesthetic drugs in elderly patients undergoing noncardiac surgery: a systematic review and meta-analysis. International Journal of Surgery, 109(1), 21-31. https://doi.org/10.1097/JS9.0000000000000001
Zhao, W., Hu, Y., Chen, H., Wang, X., Wang, L., Wang, Y., Wu, X., & Han, F. (2020). The effect and optimal dosage of dexmedetomidine plus sufentanil for postoperative analgesia in elderly patients with postoperative delirium and early postoperative cognitive dysfunction: A single-center, prospective, randomized, double-blind, controlled trial. Frontiers in Neuroscience, 14, 549516. https://doi.org/10.3389/fnins.2020.549516
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gabrielle Campos de Menezes; Lara Aladim Almeida; Maria Eduarda Galvão Xavier da Nóbrega; Vinícius Machado Moreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
